相关参考文献
注意：仅列出部分参考文献，下载原文获取全部文献信息。Chemical Proteomics and Phenotypic Profiling Identifies the Aryl Hydrocarbon Receptor as a Molecular Target of the Utrophin Modulator Ezutromid
Isabel V. L. Wilkinson et al.
ANGEWANDTE CHEMIE-INTERNATIONAL EDITION (2020)
Characterisation of utrophin modulator SMT C1100 as a non-competitive inhibitor of firefly luciferase
Isabel V. L. Wilkinson et al.
BIOORGANIC CHEMISTRY (2020)
Isolation, Structural Identification, Synthesis, and Pharmacological Profiling of 1,2-trans-Dihydro-1,2-diol Metabolites of the Utrophin Modulator Ezutromid
Maria Chatzopoulou et al.
JOURNAL OF MEDICINAL CHEMISTRY (2020)
Comparative proteomic analyses of Duchenne muscular dystrophy and Becker muscular dystrophy muscles: changes contributing to preserve muscle function in Becker muscular dystrophy patients
Daniele Capitanio et al.
JOURNAL OF CACHEXIA SARCOPENIA AND MUSCLE (2020)
Combining experimental strategies for successful target deconvolution
Isabel V. L. Wilkinson et al.
DRUG DISCOVERY TODAY (2020)
Constructing New Bioorthogonal Reagents and Reactions
R. David Row et al.
ACCOUNTS OF CHEMICAL RESEARCH (2018)
Emerging Approaches for the Identification of Protein Targets of Small Molecules - A Practitioners' Perspective
Kenneth M. Comess et al.
JOURNAL OF MEDICINAL CHEMISTRY (2018)
Fishing for Drug Targets: A Focus on Diazirine Photoaffinity Probe Synthesis
James R. Hill et al.
JOURNAL OF MEDICINAL CHEMISTRY (2018)
The potential of utrophin modulators for the treatment of Duchenne muscular dystrophy
Simon Guiraud et al.
EXPERT OPINION ON ORPHAN DRUGS (2018)
Practical Considerations, Challenges, and Limitations of Bioconjugation via Azide-Alkyne Cycloaddition
Chad J. Pickens et al.
BIOCONJUGATE CHEMISTRY (2018)
Pharmacological advances for treatment in Duchenne muscular dystrophy
Simon Guiraud et al.
CURRENT OPINION IN PHARMACOLOGY (2017)
Combinatorial therapeutic activation with heparin and AICAR stimulates additive effects on utrophin A expression in dystrophic muscles
Christine Peladeau et al.
HUMAN MOLECULAR GENETICS (2016)
Chemical proteomics approaches for identifying the cellular targets of natural products
M. H. Wright et al.
NATURAL PRODUCT REPORTS (2016)
The harmonizome: a collection of processed datasets gathered to serve and mine knowledge about genes and proteins
Andrew D. Rouillard et al.
DATABASE-THE JOURNAL OF BIOLOGICAL DATABASES AND CURATION (2016)
Safety, Tolerability, and Pharmacokinetics of SMT C1100, a 2-Arylbenzoxazole Utrophin Modulator, following Single-and Multiple-Dose Administration to Pediatric Patients with Duchenne Muscular Dystrophy
Valeria Ricotti et al.
PLOS ONE (2016)
Photoaffinity labeling in target- and binding-site identification
Ewan Smith et al.
FUTURE MEDICINAL CHEMISTRY (2015)
Firefly luciferase inhibition: a widely neglected problem
Albert Braeuning
ARCHIVES OF TOXICOLOGY (2015)
Cyclization of Gold Acetylides: Synthesis of Vinyl Sulfonates via Gold Vinylidene Complexes
Janina Bucher et al.
ANGEWANDTE CHEMIE-INTERNATIONAL EDITION (2014)
Synthesis and in vitro antitumor activity of novel 2-alkyl-5-methoxycarbonyl-11-methyl-6H-pyrido[4,3-b]carbazol-2-ium and 2-alkylellipticin-2-ium chloride derivatives
Ryota Mori et al.
EUROPEAN JOURNAL OF MEDICINAL CHEMISTRY (2014)
Defects in Mitochondrial ATP Synthesis in Dystrophin-Deficient Mdx Skeletal Muscles May Be Caused by Complex I Insufficiency
Emma Rybalka et al.
PLOS ONE (2014)
Defects in mitochondrial localization and ATP synthesis in the mdx mouse model of Duchenne muscular dystrophy are not alleviated by PDE5 inhibition
Justin M. Percival et al.
HUMAN MOLECULAR GENETICS (2013)
Chronic AMPK activation evokes the slow, oxidative myogenic program and triggers beneficial adaptations in mdx mouse skeletal muscle
Vladimir Ljubicic et al.
HUMAN MOLECULAR GENETICS (2011)
Discovery of 2-Arylbenzoxazoles as Upregulators of Utrophin Production for the Treatment of Duchenne Muscular Dystrophy
Daniel R. Chancellor et al.
JOURNAL OF MEDICINAL CHEMISTRY (2011)
Daily Treatment with SMTC1100, a Novel Small Molecule Utrophin Upregulator, Dramatically Reduces the Dystrophic Symptoms in the mdx Mouse
Jonathon M. Tinsley et al.
PLOS ONE (2011)
Pharmacological activation of PPARβ/δ stimulates utrophin A expression in skeletal muscle fibers and restores sarcolemmal integrity in mature mdx mice
Pedro Miura et al.
HUMAN MOLECULAR GENETICS (2009)
Escape from Flatland: Increasing Saturation as an Approach to Improving Clinical Success
Frank Lovering et al.
JOURNAL OF MEDICINAL CHEMISTRY (2009)
分享论文
